Bio-Rad D-10 Hemoglobin Testing System Software Recall
Bio-Rad is recalling D-10 Dual Program software due to incorrect cartridge count updates when switching programs.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the issue is a software programming error rather than a direct physical hazard.
Plain-English summary
Bio-Rad Laboratories, Inc. is recalling the D-10 Dual Program, which includes the Update Kit D-10 A1c program diskette. The recall involves 2,906 kits distributed in the United States and internationally.
The recall is being conducted because the D-10 A1c Dual Program Floppy was programmed incorrectly. This error causes cartridge injection counts to not update correctly when users switch between the D-10 Dual Short Program and the Extended Program on the D-10 Hemoglobin Testing System.
The affected products were distributed nationwide in the United States and internationally to Latin America, Asia Pacific, Canada, Australia, New Zealand, and India. Users should contact Bio-Rad Laboratories for further instructions regarding the replacement or correction of the software.
The recalled product
- Product
- D-10 Dual Program, which contains Update Kit D-10 A1c program diskette. United States; Bio-Rad Laboratories, Hercules, CA 94547 The Bio-Rad D-10 Hemoglobin Testing System provides an integrated method for the separation and determination of the relative percent of specific
- Manufacturer
- Bio-Rad Laboratories, Inc.
- Hazard
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Bio-Rad Laboratories, Inc.
See all →- HighToxoplasma IgM assay kits recalled over risk of false positive results
FDA (Devices) · 2025-09-10
- HighAPLS IgM Diagnostic Reagent Packs Recalled Due to Incorrect Conjugate
FDA (Devices) · 2023-05-17
- HighBioPlex 2200 Anti-CCP Reagent Pack Recalled for Reduced Diagnostic Specificity
FDA (Devices) · 2023-04-19
- HighBioPlex 2200 Anti-CCP Reagent Kit recalled due to reduced test specificity
FDA (Devices) · 2023-04-19
- HighCMV IgM EIA Diagnostic Test Recalled for Increased False Positives
FDA (Devices) · 2022-12-07
Same hazard · software error
See all →- HighQuantum Rehab R-TRAK Powered Wheelchair Controller Recalled Due to Software Issue
FDA (Devices) · 2026-08-12
- HighDASH Rapid PCR Instrument Recalled Due to Software Issue Causing False Co-infection Results
FDA (Devices) · 2026-08-12
- HighQuantum Outback Powered Wheelchair Controller Recalled Due to Unexpected Braking Risk
FDA (Devices) · 2026-08-12
- HighREMISOL Advance Software Version 2.5 Recalled for Incorrect Test Result Reporting
FDA (Devices) · 2026-08-12
- HighQuantum Rehab Q6 Edge 3 Powered Wheelchair Controller Recalled for Unexpected Braking
FDA (Devices) · 2026-08-12